Board MeetingOutcome of Board Meeting
Alivus Life Sciences' board approved the financial results for the quarter and half-year ended Sept 30. Q2 revenue surged to ₹587.98 Cr & net profit to ₹130.03 Cr.
Alivus Life Sciences LimitedALIVUS · Filed with the exchange
H1 revenue hit ₹1189.83 Cr, with net profit at ₹251.56 Cr, showing solid growth.
No comments yet. Be the first.